Anti-miRNA based therapy for NIDDM: Increased expression of Stress-responsive MiRNA-9 promotes gluconeogenesis and hyperglycemia via down regulation of Cyclin D1, Genome-2-Bio-Medicine Discovery center (GBMD), 8/07/2014, 6.08 am

Mechanistic insights into allergen-induced tumorigenesis: Allergen suppresses the expression of tumor suppressor RECK via up regulation of its target gene, 8/July/2014, 6.00 am
July 8, 2014
Insights into extending the longevity and survial of Haematopoietic stem cells: The epithelial-mesenchymal transition protein Snai1/Snail1 increases the longevity of hematopoietic stem cells via up regulation of its target gene, Genome-2-Bio-Medicine Discovery Center, 08/July/2014, 7.23 am
July 8, 2014
Show all

A study from the Department of Cancer Biology, Dana-Farber Cancer Institute;  Department of Cell Biology, Harvard Medical School, USA; and others shows that Cyclin D1–Cdk4 controls glucose metabolism independently of cell cycle progression.”

This study was published in the June 26, 2014 Nature [I.F >35] by Prof. Puigserver and others from the Department of Cancer Biology, Dana-Farber Cancer Institute;  Department of Cell Biology, Harvard Medical School, USA.

On the foundation of this interesting finding, Dr L Boominathan, Director-cum-chief Scientist of GBMD, reports here that: Anti-miRNA based therapy for NIDDM: Increased expression of Stress-responsive MiRNA-9 promotes gluconeogenesis and hyperglycemia via down regulation of Cyclin D1.  This study may suggest that miRNA-9, by down regulating its target gene, it may promote  gluconeogenesis and hyperglycemia. Together, this study suggests that pharmacological formulations containing “antagomiR-9 or small molecule inhibitors of miRNA-9″  can be used in the treatment of NIDDM.

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan, L., Anti-miRNA based therapy for NIDDM: Increased expression of Stress-responsive MiRNA-9 promotes gluconeogenesis and hyperglycemia via down regulation of Cyclin D1, Genome-2-Bio-Medicine Discovery center (GBMD), 8/07/2014, 6.08 am.,  http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation

Comments are closed.